Skip to main content

Table 1 Characteristics of patients in normoglycaemia and hyperglycaemia group at initiation of follow-up

From: A prospective observational study of the relationship of critical illness associated hyperglycaemia in medical ICU patients and subsequent development of type 2 diabetes

  All patients
(N = 1,029)
Patients with hyperglycaemia
(N = 360)
Patients without hyperglycaemia
(N = 669)
Hyperglycaemia vs. normoglycaemia
Diagnoses (N, %)     
- sepsisa 376 164 (43.6%) 202 (56.4%) P < 0.001
- ACSb 322 97 (30.1%) 225 (69.9%)  
- other diagnoses 331 99 (29.9%) 232 (70.1%)  
Age (years) 58 (19 to 87) 59 (22 to 87) 58 (19 to 86) P = 0.214
Male sex (N, %) 570 (55.4%) 194 (53.9%) 376 (56.2%) P = 0.781
Body mass index (kg/m2) 27.3 (17.5 to 39.8) 29.4 (17.5 to 39.8) 26.8 (17.6 to 38.5) P = 0.025
Family history of diabetes 108 (10.5%) 48 (13.3%) 60 (8.9%) P = 0.038
Triglycerides (mmol/l) 1.4 (0.9 to 4.5) 1.4 (0.9 to 4.2) 1.3 (0.9 to 4.5) P = 0.106
Cholesterol (umol/l) 4.5 (2.1 to 7.7) 4.8 (2.0 to 9.7) 4.9 (2.1 to 8.0) P = 0.146
Glucose levelsc 6.4 (2.7 to 23.5) 7.6 (3.8 to 23.5) 5.2 (2.7 to 7.7) P < 0.001
Feeding regimen (N, %)     
- enteral nutrition only 703 (68.3%) 248 (68.8%) 455 (68.1%) P = 0.823
- total parenteral or combination 326 (31.7%) 112 (31.1%) 214 (31.9%)  
Caloric intake (% of target) 85% (66 to 115) 88% (69 to 112) 84% (67 to 113) P = 0.541
  1. a includes severe sepsis and septic shock
  2. b ACS, acute coronary syndrome (unstable angina and myocardial infarction)
  3. c Medians and ranges of all measured blood glucose levels for all patients in a group
  4. Categorical data are presented as absolute and relative frequencies, continuous variables with medians with interquartile range.